ID1 and acute myeloid leukemia: Future studies are needed to determine if ID1 is required for AML cell line growth in xenotransplantation and human AML PDX models, and if the recently identified inhibitors of ID1 including cannabidiol and AGX51 show any therapeutic benefit in these models (117–119).